increased isteroannessiectomia, isteroannessiectomia with linfoadenectomia, annessiectomia with linfoadenectomia with omentectomia, removal focus of endometriosis 4 stage MedDRA version: 6.1 Level: HLT Classification code 10002092
Conditions
Interventions
Trade Name: MORF CL MOL IMIV 10MG 5F 1ML
Pharmaceutical Form: Solution for infusion
INN or Proposed INN: Morphine
CAS Number: 52-26-6
Concentration unit: mg milligram(s)
Concentration type: equal
Conc
Sponsors
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients exposed to major gynecological surgery for via laparotomy in election. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Not agreeable patients;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Secondary Objective: - Appraisal of the anaesthesiologic conduct in the surgical operation ; - Appraisal of the times of canalization, refeeding and post-operative hospitalization; - Appraisal of the satisfaction of the patients.;Primary end point(s): VAS;Main Objective: To confront, through measurement of the VAS, the validity of the post-operative analgesia in the patients exposed to intravenous analgesia with morphine in pump PCA and epidural analgesia in pump PCEA. | — |
Countries
Italy
Outcome results
None listed